AU2002242500A1 - Cathepsin cysteine protease inhibitors - Google Patents

Cathepsin cysteine protease inhibitors

Info

Publication number
AU2002242500A1
AU2002242500A1 AU2002242500A AU2002242500A AU2002242500A1 AU 2002242500 A1 AU2002242500 A1 AU 2002242500A1 AU 2002242500 A AU2002242500 A AU 2002242500A AU 2002242500 A AU2002242500 A AU 2002242500A AU 2002242500 A1 AU2002242500 A1 AU 2002242500A1
Authority
AU
Australia
Prior art keywords
protease inhibitors
cysteine protease
cathepsin cysteine
cathepsin
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002242500A
Inventor
Renata Marcella Oballa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of AU2002242500A1 publication Critical patent/AU2002242500A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002242500A 2001-03-02 2002-02-28 Cathepsin cysteine protease inhibitors Abandoned AU2002242500A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27280001P 2001-03-02 2001-03-02
US60/272,800 2001-03-02
PCT/CA2002/000258 WO2002070517A2 (en) 2001-03-02 2002-02-28 Cathepsin cysteine protease inhibitors

Publications (1)

Publication Number Publication Date
AU2002242500A1 true AU2002242500A1 (en) 2002-09-19

Family

ID=23041336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002242500A Abandoned AU2002242500A1 (en) 2001-03-02 2002-02-28 Cathepsin cysteine protease inhibitors

Country Status (2)

Country Link
AU (1) AU2002242500A1 (en)
WO (1) WO2002070517A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384970B2 (en) 2003-03-24 2008-06-10 Irm Llc Inhibitors of cathepsin S
US7109243B2 (en) 2003-03-24 2006-09-19 Irm Llc Inhibitors of cathepsin S
US7173051B2 (en) * 2003-06-13 2007-02-06 Irm, Llc Inhibitors of cathepsin S
US7256207B2 (en) 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
BRPI0613974A2 (en) 2005-07-27 2011-02-22 Hoffmann La Roche cathepsin k inhibitors
WO2008147228A1 (en) * 2007-05-31 2008-12-04 Fonterra Corporate Research And Development Limited Treatment or prevention of bone conditions
US20090291945A1 (en) * 2008-04-09 2009-11-26 Teijin Pharma Limited Cysteine protease inhibitors
WO2009128521A1 (en) * 2008-04-15 2009-10-22 帝人ファーマ株式会社 Cysteine protease inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE223408T1 (en) * 1998-02-09 2002-09-15 Dimensional Pharm Inc HETEROARYL-AMIDINES, METHYLAMIDINES AND -GUANIDINES AS PROTEASE INHIBITORS, IN PARTICULAR AS UROKINASE INHIBITORS
GB9903548D0 (en) * 1999-02-16 1999-04-07 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2002070517A3 (en) 2003-01-16
WO2002070517A2 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
AU2002305926A1 (en) Cysteine protease inhibitors
EP1272467A4 (en) Cathepsin cysteine protease inhibitors
GB0125445D0 (en) Protease Inhibitors
AU6007200A (en) Cysteine protease inhibitors
EP1694647A4 (en) Cathepsin cysteine protease inhibitors
PL370766A1 (en) Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
AU2001247589A1 (en) Non-amidine containing protease inhibitors
EP1673336A4 (en) Cathepsin cysteine protease inhibitors
AU2003234630A1 (en) Cysteine protease inhibitors
AU2002322802A1 (en) Thrombin inhibitors
AU2003256305A1 (en) Peptidic compounds as cysteine protease inhibitors
AU2560700A (en) Acylated aminoacetonitriles as cysteine protease inhibitors
AU2002242500A1 (en) Cathepsin cysteine protease inhibitors
AU2003269984A1 (en) Protease inhibitors
AU2002342682A1 (en) Protease inhibitors
AU2002351076A1 (en) Thrombin inhibitors
IL155961A0 (en) Cysteine protease inhibitors
AU2002348465A1 (en) Alpha-hydroxyarylbutanamine inhibitors of aspartyl protease
AU2003263738A1 (en) Protease inhibitors
AU2002334846A1 (en) Elastase inhibitors
AU2003292406A1 (en) Serine protease
AU2002363791A1 (en) Protease enzyme inhibitors
AU2001296247A1 (en) Cysteine protease inhibitors
AU2002325108A1 (en) Serine protease inhibitor and processes for the preparation thereof
AU2002248769A1 (en) Arylacetamido-ketobenzoxazole as cysteine protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase